Surgical treatment of gastric cancer: a 10-year experience in a high-volume university hospital

Carregando...
Imagem de Miniatura
Citações na Scopus
37
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
Faculdade de Medicina / USP
Citação
CLINICS, v.73, n.suppl 1, p.e543s, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVES: Surgery remains the cornerstone treatment modality for gastric cancer, the fifth most common type of tumor in Brazil. The aim of this study was to analyze the surgical treatment outcomes of patients with gastric cancer who were referred to a high-volume university hospital. METHODS: We reviewed all consecutive patients who underwent any surgical procedure due to gastric cancer from a prospectively collected database. Clinicopathological characteristics, surgical and survival outcomes were evaluated, with emphasis on patients treated with curative intent. RESULTS: From 2008 to 2017, 934 patients with gastric tumors underwent surgical procedures in our center. Gastric adenocarcinoma accounted for the majority of cases. Of the 875 patients with gastric adenocarcinoma, resection with curative intent was performed in 63.5%, and palliative treatment was performed in 22.4%. The postoperative surgical mortality rate for resected cases was 5.3% and was related to D1 lymphadenectomy and the presence of comorbidities. Analysis of patients treated with curative intent showed that resection extent, pT category, pN category and final pTNM stage were related to disease-free survival (DFS) and overall survival (OS). The DFS rates for D1 and D2 lymphadenectomy were similar, but D2 lymphadenectomy significantly improved the OS rate. Additionally, clinical factors and the presence of comorbidities had influence on the OS. CONCLUSIONS: TNM stage and the type of lymphadenectomy were independent factors related to prognosis. Early diagnosis should be sought to offer the optimal surgical approach in patients with less-advanced disease.
Palavras-chave
Gastric Cancer, Gastrectomy, Operative Surgical Procedures
Referências
  1. Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480
  2. Bosman T F, 2010, WHO classification of tumours of the digestive system
  3. CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
  4. da Costa WL, 2015, ANN SURG ONCOL, V22, P750, DOI 10.1245/s10434-014-4212-6
  5. Degiuli M, 2016, WORLD J GASTROENTERO, V22, P2875, DOI 10.3748/wjg.v22.i10.2875
  6. Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
  7. Doyle D J, 2017, American Society of Anesthesiologists Classification (ASA Class)
  8. Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
  9. Japanese Gastric Canc Assoc, 2017, GASTRIC CANCER, V20, P1, DOI 10.1007/s10120-016-0622-4
  10. Ramos MFKP, 2018, INT J SURG, V53, P366, DOI 10.1016/j.ijsu.2018.03.082
  11. Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4
  12. Norero E, 2017, EJSO-EUR J SURG ONC, V43, P1330, DOI 10.1016/j.ejso.2017.01.004
  13. Pereira MA, 2018, J SURG ONCOL, V117, P829, DOI 10.1002/jso.25022
  14. Pereira MA, 2018, J GASTROINTEST SURG, V22, P23, DOI 10.1007/s11605-017-3517-8
  15. Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X
  16. Strong VE, 2015, J SURG ONCOL, V112, P31, DOI 10.1002/jso.23940
  17. Strong VE, 2010, ANN SURG, V251, P640, DOI 10.1097/SLA.0b013e3181d3d29b
  18. Suda Yasuo, 1999, Gastric Cancer, V2, P165, DOI 10.1007/s101200050041
  19. Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z
  20. Zilberstein Bruno, 2004, Gastric Cancer, V7, P254, DOI 10.1007/s10120-004-0301-8
  21. Zilberstein Bruno, 2013, ABCD, arq. bras. cir. dig., V26, P2, DOI 10.1590/S0102-67202013000100002
  22. 2015, Estimativa 2016: incidência de câncer no Brasil